Home LiteratureArticle Details
PMID: 23727242 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors.

Cell reports ·Vol. 3 ·No. 6 ·2013-06-27 ·Pages 1766-76

Mead AJ, Kharazi S, Atkinson D, Macaulay I, Pecquet C, Loughran S, Lutteropp M, Woll P, Chowdhury O, Luc S, Buza-Vidas N, Ferry H, Clark SA, Goardon N, Vyas P, Constantinescu SN, Sitnicka E, Nerlov C, Jacobsen SE

Abstract

Whether signals mediated via growth factor receptors (GFRs) might influence lineage fate in multipotent progenitors (MPPs) is unclear. We explored this issue in a mouse knockin model of gain-of-function Flt3-ITD mutation because FLT3-ITDs are paradoxically restricted to acute myeloid leukemia even though Flt3 primarily promotes lymphoid development during normal hematopoiesis. When expressed in MPPs, Flt3-ITD collaborated with Runx1 mutation to induce high-penetrance aggressive leukemias that were exclusively of the myeloid phenotype. Flt3-ITDs preferentially expanded MPPs with reduced lymphoid and increased myeloid transcriptional priming while compromising early B and T lymphopoiesis. Flt3-ITD-induced myeloid lineage bias involved upregulation of the transcription factor Pu.1, which is a direct target gene of Stat3, an aberrantly activated target of Flt3-ITDs, further establishing how lineage bias can be inflicted on MPPs through aberrant GFR signaling. Collectively, these findings provide new insights into how oncogenic mutations might subvert the normal process of lineage commitment and dictate the phenotype of resulting malignancies.

MeSH Terms
Animals Cell Differentiation/physiology Cell Transformation, Neoplastic/genetics,metabolism,pathology Disease Models, Animal Flow Cytometry/methods Gene Expression Humans Leukemia, Myeloid, Acute/genetics,metabolism,pathology Mice Microarray Analysis Multipotent Stem Cells/cytology,immunology,metabolism,pathology Myeloid Cells/cytology,immunology,metabolism,pathology Signal Transduction fms-Like Tyrosine Kinase 3/genetics,metabolism,physiology
Chemicals
FLT3 protein, human Flt3 protein, mouse fms-Like Tyrosine Kinase 3
Authors & Affiliations
19 authors, click to expand affiliations / ORCID
Mead Adam J
Haematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK. [email protected]
Kharazi Shabnam
Atkinson Deborah
Macaulay Iain
Pecquet Christian
Loughran Stephen
Lutteropp Michael
Woll Petter
Chowdhury Onima
Luc Sidinh
Buza-Vidas Natalija
Ferry Helen
Clark Sally-Ann
Goardon Nicolas
Vyas Paresh
Constantinescu Stefan N
Sitnicka Ewa
Nerlov Claus
Jacobsen Sten Eirik W
References (45)
45 references, click to expand
  1. Lineage specification and plasticity in CD19- early B cell precursors.
    J Exp Med. 2006 Mar 20;203(3):675-87 PMID: 16505143
  2. Transgenic mice with hematopoietic and lymphoid specific expression of Cre.
    Eur J Immunol. 2003 Feb;33(2):314-25 PMID: 12548562
  3. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment.
    Cell. 2005 Apr 22;121(2):295-306 PMID: 15851035
  4. Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation.
    Blood. 2011 Sep 29;118(13):3613-21 PMID: 21813452
  5. Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor.
    Blood. 2010 Feb 4;115(5):1037-48 PMID: 19996410
  6. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool.
    Immunity. 2002 Oct;17(4):463-72 PMID: 12387740
  7. Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma.
    Blood. 2005 Nov 15;106(10):3621-4 PMID: 16051740
  8. The Immunological Genome Project: networks of gene expression in immune cells.
    Nat Immunol. 2008 Oct;9(10):1091-4 PMID: 18800157
  9. Stat3 promotes the development of erythroleukemia by inducing Pu.1 expression and inhibiting erythroid differentiation.
    Oncogene. 2009 Sep 24;28(38):3349-59 PMID: 19581930
  10. AML1 deletion in adult mice causes splenomegaly and lymphomas.
    Oncogene. 2006 Feb 9;25(6):929-39 PMID: 16247465
  11. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation.
    Blood. 2005 Sep 1;106(5):1590-600 PMID: 15914556
  12. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.
    Nature. 2012 Jan 11;481(7382):506-10 PMID: 22237025
  13. FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model.
    Blood. 2005 Jun 15;105(12):4792-9 PMID: 15718420
  14. RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis.
    Blood. 2011 Feb 24;117(8):2348-57 PMID: 21148331
  15. Regulation of B lymphocyte and macrophage development by graded expression of PU.1.
    Science. 2000 May 26;288(5470):1439-41 PMID: 10827957
  16. FLT3 mutation and expression did not adversely affect clinical outcome of childhood acute leukaemia: a study of 531 Southeast Asian children by the Ma-Spore study group.
    Hematol Oncol. 2011 Dec;29(4):211-9 PMID: 21387358
  17. The role of FLT3 in haematopoietic malignancies.
    Nat Rev Cancer. 2003 Sep;3(9):650-65 PMID: 12951584
  18. Down-regulation of Mpl marks the transition to lymphoid-primed multipotent progenitors with gradual loss of granulocyte-monocyte potential.
    Blood. 2008 Apr 1;111(7):3424-34 PMID: 18218856
  19. Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality.
    Blood. 2009 Apr 9;113(15):3568-76 PMID: 19204327
  20. Summaries of Affymetrix GeneChip probe level data.
    Nucleic Acids Res. 2003 Feb 15;31(4):e15 PMID: 12582260
  21. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells.
    Cell. 2005 Jul 1;121(7):1109-21 PMID: 15989959
  22. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Sci Transl Med. 2012 Aug 29;4(149):149ra118 PMID: 22932223
  23. Hematopoietic cytokines can instruct lineage choice.
    Science. 2009 Jul 10;325(5937):217-8 PMID: 19590005
  24. Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia.
    Haematologica. 2011 Dec;96(12):1874-7 PMID: 21828118
  25. Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors.
    Immunity. 2007 Apr;26(4):407-19 PMID: 17433729
  26. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
    Nature. 2012 Apr 15;485(7397):260-3 PMID: 22504184
  27. Inducible gene targeting in mice.
    Science. 1995 Sep 8;269(5229):1427-9 PMID: 7660125
  28. Internal tandem duplications of the FLT3 gene are present in leukemia stem cells.
    Blood. 2005 Jul 15;106(2):673-80 PMID: 15797998
  29. FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm.
    Cell Stem Cell. 2012 Sep 7;11(3):346-58 PMID: 22958930
  30. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors.
    Cancer Res. 2005 Jun 15;65(12):5054-62 PMID: 15958548
  31. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
    Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 PMID: 16199517
  32. Hematopoietic fingerprints: an expression database of stem cells and their progeny.
    Cell Stem Cell. 2007 Nov;1(5):578-91 PMID: 18371395
  33. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.
    Blood. 2008 Mar 1;111(5):2776-84 PMID: 17957027
  34. Selective thymus settling regulated by cytokine and chemokine receptors.
    J Immunol. 2007 Feb 15;178(4):2008-17 PMID: 17277104
  35. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
    Nat Genet. 2006 Nov;38(11):1269-77 PMID: 17041602
  36. Developmental biology: Instructions writ in blood.
    Nature. 2009 Sep 10;461(7261):183-4 PMID: 19741696
  37. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.
    Cancer Cell. 2011 Jan 18;19(1):138-52 PMID: 21251617
  38. FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia.
    Cancer Cell. 2007 Oct;12(4):367-80 PMID: 17936561
  39. Oncogenes and cancer.
    N Engl J Med. 2008 Jan 31;358(5):502-11 PMID: 18234754
  40. Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model.
    Blood. 2008 Apr 1;111(7):3849-58 PMID: 18245664
  41. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype.
    Blood. 2005 Jul 15;106(2):494-504 PMID: 15784726
  42. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block.
    Nat Immunol. 2006 Oct;7(10):1048-56 PMID: 16951689
  43. Linear models and empirical bayes methods for assessing differential expression in microarray experiments.
    Stat Appl Genet Mol Biol. 2004;3:Article3 PMID: 16646809
  44. Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis.
    Blood. 2010 Feb 25;115(8):1610-20 PMID: 20008790
  45. The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential.
    Nat Immunol. 2012 Feb 19;13(4):412-9 PMID: 22344248
Article Info
Journal
Cell reports
Abbr.
Cell Rep
ISSN
2211-1247
Published
2013-06-27
Epub
2013-00-30
Pages
1766-76
Language
English
Region
United States
NLM ID
101573691
PMCID
PMC3701326
Subset
IM
Grants
Medical Research Council · G84/6443 · United Kingdom
Medical Research Council · MC_PC_12020 · United Kingdom
Medical Research Council · MC_U137961146 · United Kingdom
Medical Research Council · G0801073 · United Kingdom
Medical Research Council · MC_UU_12009/5 · United Kingdom
Medical Research Council · G0501838 · United Kingdom
Medical Research Council · G1000729 · United Kingdom
Medical Research Council · G0900892 · United Kingdom
Databases
GEO
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]